Ellevest, Inc. Charles River Laboratories International, Inc. Transaction History

Ellevest, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$191.89 - $259.92 $4,413 - $5,978	-23 Reduced 52.27%	21 $4,000
Q4 2022 Feb 03, 2023	SELL	$197.11 - $250.07 $10,446 - $13,253	-53 Reduced 54.64%	44 $9,000
Q3 2022 Nov 02, 2022	SELL	$182.44 - $250.54 $18,061 - $24,803	-99 Reduced 50.51%	97 $19,000
Q2 2022 Jul 18, 2022	SELL	$204.13 - $302.4 $46,745 - $69,249	-229 Reduced 53.88%	196 $42,000
Q1 2022 Apr 19, 2022	BUY	$255.51 - $362.11 $46,247 - $65,541	181 Added 74.18%	425 $121,000
Q4 2021 Jan 24, 2022	BUY	$351.38 - $448.68 $19,677 - $25,126	56 Added 29.79%	244 $92,000
Q2 2021 Jul 13, 2021	SELL	$294.17 - $371.65 $2,647 - $3,344	-9 Reduced 4.57%	188 $70,000
Q1 2021 May 03, 2021	BUY	$249.67 - $299.48 $27,963 - $33,541	112 Added 131.76%	197 $57,000
Q4 2020 Feb 04, 2021	BUY	$222.0 - $252.62 $10,878 - $12,378	49 Added 136.11%	85 $21,000
Q3 2020 Oct 26, 2020	BUY	$175.56 - $226.45 $3,686 - $4,755	21 Added 140.0%	36 $8,000
Q2 2020 Jul 06, 2020	BUY	$118.84 - $189.72 $1,782 - $2,845	15 New	15 $3,000
Q2 2019 Aug 20, 2019	SELL	$123.4 - $148.55 $2,468 - $2,971	-20 Closed	0 $0
Q1 2019 May 01, 2019	BUY	$104.82 - $146.73 $2,096 - $2,934	20 New	20 $3,000

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.56B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.